Continuous Manufacturing in Pharmaceuticals: Implications for the Generics Market
REPORT INCLUDES:
- A market outlook of Continuous Manufacturing (CM) in pharmaceuticals and biopharmaceuticals market
- Analyses of global CM market trends, with data from 2017-2018, estimates for 2019 and projections of CAGRs through 2024
- Information on the role of U.S. FDA in the growing popularity of CM, the changing mindset of pharmaceutical sector, and other factors that are impacting the adoption of CM in pharmaceuticals sector
- A look at generic drugs market and future trends for CM
- Patent analysis highlighting the innovation in CM
CHAPTER 1 TECHNOLOGY HIGHLIGHTS AND MARKET OUTLOOK
What is Continuous Manufacturing?
How is CM Beneficial to the Pharmaceutical Industry?
What is the Status of Continuous Bioprocessing?
Industry Examples
What is FDA's Role in the Growing Popularity of CM?
What Other Factors Are Driving the Adoption of CM?
Growing Demand for Drugs
Desire to Reduce Costs and Increase Product Quality
PAT Guidance
Drive Toward Digitalization
Partnerships and Collaborations
Innovation in Technology
Which Pharmaceuticals Are Still Reluctant to Introduce CM at Full Scale?
Traditional Mindset
Cost of Transformation
CM Not Suitable for All Product Types
Requirement of Skilled Personnel
Lack of Experience and Data
Generics Drug Market and CM
Generic Drugs Compete with the Branded Drugs
Manufacturing Process is the Deciding Factor
Lurking Issues for the Generics Sector
Is Continuous Manufacturing the Solution for Generics Manufacturers?
Latest FDA Guidance-What is the Future?
Market Outlook for CM in Pharmaceuticals and Biopharmaceuticals
Market by Type
Market by End User
Market by Region
Brief Patent Analysis Highlighting Innovation in CM
Patents by Year
Patents by Type
Patents by Assignee
Major Players in the CM Market
Market Shares
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
What is Continuous Manufacturing?
How is CM Beneficial to the Pharmaceutical Industry?
What is the Status of Continuous Bioprocessing?
Industry Examples
What is FDA's Role in the Growing Popularity of CM?
What Other Factors Are Driving the Adoption of CM?
Growing Demand for Drugs
Desire to Reduce Costs and Increase Product Quality
PAT Guidance
Drive Toward Digitalization
Partnerships and Collaborations
Innovation in Technology
Which Pharmaceuticals Are Still Reluctant to Introduce CM at Full Scale?
Traditional Mindset
Cost of Transformation
CM Not Suitable for All Product Types
Requirement of Skilled Personnel
Lack of Experience and Data
Generics Drug Market and CM
Generic Drugs Compete with the Branded Drugs
Manufacturing Process is the Deciding Factor
Lurking Issues for the Generics Sector
Is Continuous Manufacturing the Solution for Generics Manufacturers?
Latest FDA Guidance-What is the Future?
Market Outlook for CM in Pharmaceuticals and Biopharmaceuticals
Market by Type
Market by End User
Market by Region
Brief Patent Analysis Highlighting Innovation in CM
Patents by Year
Patents by Type
Patents by Assignee
Major Players in the CM Market
Market Shares
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
LIST OF TABLES
Table 1: Continuous Manufacturing vs. Batch Manufacturing
Table 2: FDA Approved Continuously Manufactured Drugs
Table 3: Collaborations and Partnerships in the Continuous Manufacturing Market, 2017 to Sept. 2018
Table 4: FDA Guidance Analysis
Table 5: Global Market for Continuous Manufacturing, by Type, Through 2024
Table 6: Global Market Shares of Continuous Manufacturing, by Type, 2018
Table 7: Global Market for Continuous Manufacturing, by End User, Through 2024
Table 8: Global Market Shares of Continuous Manufacturing, by End User, 2018
Table 9: Global Market for Continuous Manufacturing, by Region, Through 2024
Table 10: Global Market Shares of Continuous Manufacturing, by Region, 2018
Table 11: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
Table 12: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
Table 13: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
Table 14: Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
Table 15: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
Table 1: Continuous Manufacturing vs. Batch Manufacturing
Table 2: FDA Approved Continuously Manufactured Drugs
Table 3: Collaborations and Partnerships in the Continuous Manufacturing Market, 2017 to Sept. 2018
Table 4: FDA Guidance Analysis
Table 5: Global Market for Continuous Manufacturing, by Type, Through 2024
Table 6: Global Market Shares of Continuous Manufacturing, by Type, 2018
Table 7: Global Market for Continuous Manufacturing, by End User, Through 2024
Table 8: Global Market Shares of Continuous Manufacturing, by End User, 2018
Table 9: Global Market for Continuous Manufacturing, by Region, Through 2024
Table 10: Global Market Shares of Continuous Manufacturing, by Region, 2018
Table 11: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
Table 12: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
Table 13: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
Table 14: Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
Table 15: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
LIST OF FIGURES
Figure 1: Pharmaceutical Continuous vs. Batch Manufacturing Process
Figure 2: Global Market for Continuous Manufacturing, by Type, 2017-2024
Figure 3: Global Market Shares of Continuous Manufacturing, by Type, 2018
Figure 4: Global Market for Continuous Manufacturing, by End User, 2017-2024
Figure 5: Global Market Shares of Continuous Manufacturing, by End User, 2018
Figure 6: Global Market for Continuous Manufacturing, by Region, 2017-2024
Figure 7: Global Market Shares of Continuous Manufacturing, by Region, 2018
Figure 8: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
Figure 9: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
Figure 10: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
Figure 11: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
Figure 1: Pharmaceutical Continuous vs. Batch Manufacturing Process
Figure 2: Global Market for Continuous Manufacturing, by Type, 2017-2024
Figure 3: Global Market Shares of Continuous Manufacturing, by Type, 2018
Figure 4: Global Market for Continuous Manufacturing, by End User, 2017-2024
Figure 5: Global Market Shares of Continuous Manufacturing, by End User, 2018
Figure 6: Global Market for Continuous Manufacturing, by Region, 2017-2024
Figure 7: Global Market Shares of Continuous Manufacturing, by Region, 2018
Figure 8: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
Figure 9: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
Figure 10: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
Figure 11: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
